428. VSV Produced in CD55 Expressing Cells Has Better Resistance To Neutralization With Non-Immune Human Serum

Journal article

Open access

Peer reviewed

Mulu Z Tesfay, Arun Ammayappan, Mark J Federspiel, Glen N Barber, Kah-Whye Peng and Stephen J Russell

Molecular therapy, Vol.23, pp.S169-S169

2015-05

Files and links (1)

url

https://doi.org/10.1016/S1525-0016(16)34037-0View

Published (Version of record) Open

4 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 428. VSV Produced in CD55 Expressing Cells Has Better Resistance To Neutralization With Non-Immune Human Serum
Creators: Mulu Z Tesfay - Department of Molecular Medicine, Mayo Clinic, Rochester, MN
Arun Ammayappan - Department of Molecular Medicine, Mayo Clinic, Rochester, MN
Mark J Federspiel - Department of Molecular Medicine, Mayo Clinic, Rochester, MN
Glen N Barber - 3Department of Medicine and Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
Kah-Whye Peng - Department of Molecular Medicine, Mayo Clinic, Rochester, MN
Stephen J Russell - Department of Molecular Medicine, Mayo Clinic, Rochester, MN
Publication Details: Molecular therapy, Vol.23, pp.S169-S169
Publisher: Elsevier Inc
Academic Unit: Leadership Department; Miller School of Medicine; Cell Biology Research
Language: English
Resource Type: Journal article
Record Identifier: 991031600460502976